Korro Bio, Inc. (KRRO)
NASDAQ: KRRO · Real-Time Price · USD
13.68
-0.05 (-0.36%)
Aug 26, 2026, 4:00 PM EDT - Market closed
Korro Bio Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 2.38 | 3.84 | 6.39 | 7.37 | 6.28 | 4.82 | 2.27 | - | - | - | - | - | - | - | - | - | |
Revenue Growth (YoY) | -62.08% | -20.31% | 181.46% | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue | 43.41 | 48.17 | 55.13 | 59.82 | 61.64 | 60.04 | 52.31 | 86.13 | 73.04 | 58.76 | 48 | - | - | - | - | - |
Gross Profit | -41.02 | -44.33 | -48.74 | -52.44 | -55.36 | -55.22 | -50.04 | -86.13 | -73.04 | -58.76 | -48 | - | - | - | - | - |
Selling, General & Admin | 35.88 | 38.43 | 38.6 | 40.82 | 41.96 | 40.26 | 41.87 | 45.08 | 42.67 | 41.34 | 36.54 | 27.82 | 26.76 | 23.22 | 21.39 | 14.06 |
Research & Development | - | - | - | - | - | - | - | -35.45 | -24.09 | -14.2 | - | 46.28 | 43.93 | 42.23 | 37.61 | 21.43 |
Operating Expenses | 35.88 | 38.43 | 38.6 | 40.82 | 41.96 | 40.26 | 41.87 | 9.63 | 18.58 | 27.14 | 36.54 | 74.1 | 70.69 | 65.45 | 59 | 35.49 |
Operating Income | -76.9 | -82.76 | -87.34 | -93.27 | -97.32 | -95.48 | -91.91 | -95.76 | -91.62 | -85.9 | -84.53 | -74.1 | -70.69 | -65.45 | -59 | -35.49 |
Interest Expense | -0.86 | -0.73 | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest & Investment Income | - | - | - | 3.07 | 3.07 | 1.63 | - | - | - | - | - | - | - | - | - | - |
Other Non Operating Income (Expenses) | 5.23 | 5.23 | 5.23 | 3.12 | 4.23 | 6.56 | 8.47 | 7.99 | 6.37 | 4.82 | 3.39 | 2.36 | 2.06 | 1.4 | 0.98 | 13.54 |
EBT Excluding Unusual Items | -72.53 | -78.25 | -82.11 | -87.08 | -90.03 | -87.29 | -83.44 | -87.77 | -85.25 | -81.08 | -81.15 | -71.74 | -68.63 | -64.05 | -58.02 | -21.96 |
Merger & Restructuring Charges | -2.39 | -3.63 | -3.63 | -1.23 | -1.23 | - | - | - | - | - | - | - | - | - | - | - |
Asset Writedown | -30.89 | -30.89 | -30.89 | - | - | - | - | - | - | - | - | - | - | - | - | - |
Pretax Income | -105.81 | -112.77 | -116.62 | -88.31 | -91.26 | -87.29 | -83.44 | -87.77 | -85.25 | -81.08 | -81.15 | -71.74 | -68.63 | -64.05 | -58.02 | -21.96 |
Income Tax Expense | 0.84 | 0.73 | 0.64 | 0.1 | 0.1 | 0.12 | 0.14 | 0.04 | 0.05 | 0.04 | 0.03 | 0.04 | 0.04 | 0.01 | 0.01 | 0 |
Net Income | -106.64 | -113.5 | -117.26 | -88.42 | -91.36 | -87.41 | -83.58 | -87.81 | -85.3 | -81.12 | -81.17 | -71.78 | -68.67 | -64.06 | -58.03 | -21.96 |
Net Income to Common | -106.64 | -113.5 | -117.26 | -88.42 | -91.36 | -87.41 | -83.58 | -87.81 | -85.3 | -81.12 | -81.17 | -71.78 | -68.67 | -64.06 | -58.03 | -21.96 |
Net Income Growth (YoY) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Shares Outstanding (Basic) | 12 | 10 | 9 | 9 | 9 | 9 | 9 | 8 | 6 | 3 | 2 | 6 | 6 | 6 | 0 | 4 |
Shares Outstanding (Diluted) | 12 | 10 | 9 | 9 | 9 | 9 | 9 | 8 | 6 | 3 | 2 | 6 | 6 | 6 | 0 | 4 |
Shares Change (YoY) | 28.33% | 7.42% | 5.32% | 18.77% | 65.89% | 167.19% | 483.30% | 31.62% | -0.02% | -37.27% | 499.32% | - | - | - | -94.26% | - |
EPS (Basic) | -8.88 | -11.41 | -12.48 | -9.42 | -9.76 | -9.44 | -9.37 | -11.11 | -15.11 | -23.40 | -53.08 | -11.96 | -12.16 | -11.59 | -227.42 | -4.94 |
EPS (Diluted) | -8.88 | -11.41 | -12.48 | -9.42 | -9.76 | -9.44 | -9.37 | -11.11 | -15.11 | -23.40 | -53.08 | -11.96 | -12.16 | -11.59 | -227.42 | -4.94 |
EPS Growth (YoY) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Additional Metrics
Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -68.27 | -70.6 | -79.08 | -70.24 | -73.86 | -75.05 | -77.98 | -91.79 | -82.84 | -81.42 | -75.12 | -68.8 | -72.71 | -66.04 | -58.86 | -36.54 |
Free Cash Flow Per Share | -5.68 | -7.10 | -8.42 | -7.49 | -7.89 | -8.10 | -8.74 | -11.62 | -14.68 | -23.49 | -49.12 | -11.46 | -12.88 | -11.95 | -230.65 | -8.22 |
Operating Margin | -3228.34% | -2154.03% | -1366.43% | -1265.31% | -1549.45% | -1980.44% | -4047.12% | - | - | - | - | - | - | - | - | - |
Profit Margin | -4477.08% | -2954.14% | -1834.48% | -1199.53% | -1454.47% | -1813.13% | -3680.36% | - | - | - | - | - | - | - | - | - |
Free Cash Flow Margin | -2865.87% | -1837.66% | -1237.16% | -952.92% | -1175.91% | -1556.63% | -3433.55% | - | - | - | - | - | - | - | - | - |
EBITDA | -74.33 | -79.32 | -83.06 | -88.38 | -92.75 | -91.41 | -88.35 | -92.47 | -88.27 | -82.35 | -80.9 | -70.71 | -67.53 | -62.64 | -56.49 | -33.9 |
D&A For EBITDA | 2.57 | 3.44 | 4.28 | 4.88 | 4.57 | 4.06 | 3.57 | 3.3 | 3.35 | 3.55 | 3.63 | 3.4 | 3.16 | 2.81 | 2.51 | 1.6 |
EBIT | -76.9 | -82.76 | -87.34 | -93.27 | -97.32 | -95.48 | -91.91 | -95.76 | -91.62 | -85.9 | -84.53 | -74.1 | -70.69 | -65.45 | -59 | -35.49 |